Clinical Trial Update: Antiarrhythmic Drugs Assessment in Preventing Atrial Fibrillation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating antiarrhythmic drugs for the prevention of atrial fibrillation, with sponsor Xinhua Hospital and Shanghai Jiao Tong Uni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Atrial Fibrillation | Phase 4 | Status: UNKNOWN